STUDIES ON MENINGOCOCCUS INFECTION : VII. THE STUDY OF AN ISOLATED EPIDEMIC

G Rake1

  • 1Laboratories of The Rockefeller Institute for Medical Research.

Insights

This study examined meningococcus meningitis carriers, finding Type I strains highly virulent and Type II moderately so. Carrier state didn't correlate with respiratory illness but showed immune responses like antibodies.

Area of Science:

  • Microbiology
  • Epidemiology
  • Immunology

Background:

  • Meningococcus meningitis outbreaks highlight the importance of understanding the carrier state.
  • Previous research on pneumococcus carriers suggests a link with respiratory conditions, prompting investigation into meningococcal carriers.

Purpose of the Study:

  • To investigate the virulence of meningococcal strains carried by individuals during an isolated epidemic.
  • To explore the relationship between the meningococcal carrier state and host immune responses.
  • To determine if upper respiratory symptoms are associated with meningococcal carriage.

Main Methods:

  • Utilized Miller's technique to enhance and assess the virulence of meningococcal strains isolated from carriers.
  • Analyzed blood sera from carriers for the presence of agglutinins and protective antibodies against homologous strains.
  • Correlated carrier status with reported pharyngitis, coryza, and other upper respiratory diseases.

Main Results:

  • Type I meningococcal strains exhibited high virulence, Type II strains showed moderate virulence, and atypical strains/N. catarrhalis displayed low virulence.
  • No significant association was found between respiratory illnesses and the presence or degree of meningococcal carriage.
  • A substantial percentage of carriers demonstrated measurable agglutinins (Type I: 32.3%, Type II: 60%) and protective antibodies (Type I: 80%, Type II: 40%) in their sera.

Conclusions:

  • Meningococcal carrier strains vary significantly in virulence, with Type I being the most potent.
  • Host immune responses, including antibody production, are detectable in meningococcal carriers, irrespective of respiratory symptoms.
  • Further research is needed to understand the relationship between serological reactions and the duration of the carrier state.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...